Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline immune signatures are associated with prospective COVID-19 infection and clinical outcomes in healthcare workers: Evidence from a cohort study in Brazil.

Immunology letters·2026
Same author

Vitamin E in dermatology.

Clinics in dermatology·2026
Same author

A probable case of hyaluronic acid injection-induced MAST cell activation syndrome with refractory vasoplegia: A rare complication reversed with hyaluronidase.

JAAD case reports·2025
Same author

Ultrasound-Based Differentiation of Esthetic Abscess: Insights From Clinical Practice.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine·2025
Same author

Soluble HLA-G is related to malignant melanocytic lesions and previous oncological disease may increase circulating HLA-G bearing large extracellular vesicles.

Frontiers in immunology·2025
Same author

Management of Hyaluronic Acid Filler-Induced Refractory Sterile Abscess With Modified Munhoz-Cavallieri Lavage Protocol: A Case Series.

Journal of cosmetic dermatology·2025

Related Experiment Video

Updated: Jul 11, 2026

Reconstruct Human Retinoblastoma In Vitro
06:52

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

Reticulohistiocytosis.

Flávio Barbosa Luz1, Patricia Shu Kurizky, Marcia Ramos-e-Silva

  • 1General Policlinics of Rio de Janeiro/Carlos Chagas Medical Post-Graduation Institute, Rua Desembargador Izidro 28/1001, 20521-160 Rio de Janeiro, Brazil.

Dermatologic Clinics
|October 2, 2007
PubMed
Summary

Reticulohistiocytoses are rare diseases driven by CD68+ macrophage proliferation. Understanding the involved receptors advances knowledge of their pathology and improves patient treatment strategies.

Area of Science:

  • Immunology
  • Dermatology
  • Pathology

Background:

  • Reticulohistiocytoses are uncommon conditions characterized by the abnormal proliferation of CD68-positive macrophages.
  • Recent research has focused on identifying the specific receptors implicated in the pathogenesis of these disorders.

Purpose of the Study:

  • To review and synthesize current knowledge on the receptors involved in reticulohistiocytoses.
  • To elucidate the physiopathologic mechanisms underlying these rare diseases.
  • To guide the development of improved therapeutic strategies for affected patients.

Main Methods:

  • Literature review of recent advances in reticulohistiocytoses research.
  • Analysis of studies focusing on macrophage receptors and their role in disease.

Related Experiment Videos

Last Updated: Jul 11, 2026

Reconstruct Human Retinoblastoma In Vitro
06:52

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

Main Results:

  • Identification of key receptors contributing to CD68+ macrophage proliferation in reticulohistiocytoses.
  • Elucidation of signaling pathways influenced by these receptors.

Conclusions:

  • Advances in understanding receptor involvement are crucial for deciphering reticulohistiocytoses pathophysiology.
  • This knowledge is expected to facilitate the development of targeted and more effective therapies.